stockrowRedhill Biopharma Ltd. (RDHL) vs Sunshine Biopharma, Inc. (SBFM)
- Redhill Biopharma Ltd. RDHL 0.43 0.00%
- Sunshine Biopharma, Inc. SBFM 2.71 −2.87%
Redhill Biopharma Ltd. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $3.8M against $2.1M — 1.8× the size. Sunshine Biopharma, Inc. grew revenue faster over the last twelve months: −2.74% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −16.5%) and the higher return on invested capital (0.00% vs −26.7%). Across the 16 metrics below, Redhill Biopharma Ltd. leads on 10 and Sunshine Biopharma, Inc. on 6.
Valuation
| Metric | RDHL | SBFM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.55 |
| P/S | 0.00 | 0.01 | 2.08 |
| P/B | n/m | 0.01 | 1.79 |
| Price to free cash flow | n/m | n/m | 16.29 |
| EV/EBITDA | n/m | 2.40 | 12.22 |
| EV/Sales | 6.43 | (0.33) | 2.87 |
| Earnings yield | (142,015.51%) | (6,843.57%) | (15.94%) |
| Free cash flow yield | (231,394.02%) | (2,844.26%) | 0.00% |
Profitability
| Metric | RDHL | SBFM | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 35.16% | 30.30% | 53.51% |
| Operating margin | 0.00% | (16.65%) | 0.00% |
| Net margin | 25.20% | (16.50%) | (2.45%) |
| Free cash flow margin | 0.00% | (15.66%) | 0.00% |
| Return on equity | 0.00% | (21.93%) | (0.80%) |
| Return on assets | 0.00% | (17.78%) | (1.67%) |
| Return on invested capital | 0.00% | (26.67%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack